A majority of pediatric cancer providers endorse the use of medical marijuana for children with advanced cancer, according to results of a multicenter survey published in Pediatrics.
However, providers who are legally eligible to certify medical marijuana use appeared more cautious, results showed.
“Patients and families were asking us about medical marijuana all the time, although we knew there was not a lot of scientific evidence behind it. We wanted to get a better sense of how much it was permeating clinical practice,” Prasanna Ananth, MD, MPH, pediatric oncologist at Yale Cancer Center and assistant professor of pediatrics at Yale School of Medicine, said in a press release.
Ananth and colleagues conducted a survey of 288 pediatric oncology providers (median age, 35 years) in Illinois, Massachusetts and Washington to determine medical marijuana practices, knowledge, attitudes and barriers.
Researchers stratified providers by whether they were legally eligible to certify for medical marijuana (33%).
Thirty percent of providers reported receiving one or more requests for medical marijuana during the previous month; however,